Time to re-look at a not-so-glamorous part of healthcare ecosystem: 4 diagnostics stocks with upside potential of up to 18%

When companies from a sector with a clear growth path get listed, too much money flows into them, sending valuations high. What follows is a long phase of consolidation and valuation readjustment. This readjustment is painful and sparks different narratives – some negative, some positive. So, to reinvest in such a sector, one needs to look beyond narratives.